Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for Covid-19 severity and fatality: a structured literature review
Dominik Wolff, Sarah Nee, Natalie Sandy Hickey, et al.
Infection (2020) Vol. 49, Iss. 1, pp. 15-28
Open Access | Times Cited: 490

Showing 1-25 of 490 citing articles:

Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1307
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer, et al.
Nature Medicine (2020) Vol. 27, Iss. 2, pp. 270-278
Open Access | Times Cited: 572
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Jinjin Zhang, Xiang Dong, Guanghui Liu, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 64, Iss. 1, pp. 90-107
Open Access | Times Cited: 525
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
Adam Booth, Angus B. Reed, Sonia Ponzo, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247461-e0247461
Open Access | Times Cited: 487
Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
Sherry Chou, Ettore Beghi, Raimund Helbok, et al.
JAMA Network Open (2021) Vol. 4, Iss. 5, pp. e2112131-e2112131
Open Access | Times Cited: 359
Coronavirus Disease 2019 (COVID-19)
Michael A. Wilson, Philippa J. K. Wilson
Springer eBooks (2021), pp. 185-196
Closed Access | Times Cited: 228
SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
Lucy Thorne, Ann‐Kathrin Reuschl, Lorena Zuliani‐Alvarez, et al.
The EMBO Journal (2021) Vol. 40, Iss. 15
Open Access | Times Cited: 203
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
Francisco Javier Gil‐Etayo, Patricia Suàrez-Fernández, Óscar Cabrera-Marante, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 147
Covid-19 and non-communicable diseases: evidence from a systematic literature review
Zlatko Nikoloski, Ada Alqunaibet, Rasha Abdulrahman Alfawaz, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 118
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
Désirée van der Heijde, Xenofon Baraliakos, Joachim Sieper, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 11, pp. 1515-1523
Open Access | Times Cited: 87
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe
Constantine Vardavas, Alexander G. Mathioudakis, Katerina Nikitara, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220098-220098
Open Access | Times Cited: 82
The Microbiota in Long COVID
Carmen Álvarez-Santacruz, Sylwia D. Tyrkalska, Sergio Candel
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1330-1330
Open Access | Times Cited: 19
Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation
Fuyong Li, Anissa M. Armet, Katri Korpela, et al.
Cell (2025)
Open Access | Times Cited: 6
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
Giuseppe Lisco, Anna De Tullio, Emilio Jirillo, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 9, pp. 1801-1814
Open Access | Times Cited: 100
Neuropathological findings from COVID‐19 patients with neurological symptoms argue against a direct brain invasion of SARS‐CoV‐2: A critical systematic review
Giuseppe Cosentino, Massimiliano Todisco, Noy Hota, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 11, pp. 3856-3865
Open Access | Times Cited: 91
Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine
Ori Snapiri, Chen Rosenberg Danziger, Nina Shirman, et al.
The Pediatric Infectious Disease Journal (2021) Vol. 40, Iss. 10, pp. e360-e363
Open Access | Times Cited: 73
Vitamin D and Its Potential Benefit for the COVID-19 Pandemic
Nipith Charoenngam, Arash Shirvani, Michael F. Holick
Endocrine Practice (2021) Vol. 27, Iss. 5, pp. 484-493
Open Access | Times Cited: 72
SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19
Vivian Glück, Sonja Grobecker, Leonid Tydykov, et al.
Infection (2021) Vol. 49, Iss. 4, pp. 739-746
Open Access | Times Cited: 58
Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19
Jia Li, Rong Liu, Ran Cui, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 4, pp. 3706-3714
Open Access | Times Cited: 57
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 44
Effective health systems facing pandemic crisis: lessons from COVID-19 in Europe for next emergencies
Mario Coccia, Igor Benati
International Journal of Health Governance (2024) Vol. 29, Iss. 2, pp. 89-111
Closed Access | Times Cited: 10
Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial
Anant Mohan, Pawan Tiwari, Tejas Menon Suri, et al.
Journal of Infection and Chemotherapy (2021) Vol. 27, Iss. 12, pp. 1743-1749
Open Access | Times Cited: 53
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Kenechukwu Obumneme Samuel Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 53
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19
Lili Ren, Yeming Wang, Jiaxin Zhong, et al.
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 204, Iss. 12, pp. 1379-1390
Open Access | Times Cited: 48
Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital
Verena Schöning, Evangelia Liakoni, Christine Baumgartner, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top